Publication | Closed Access

The effects of oral and transdermal hormone replacement therapy on C-reactive protein levels and other inflammatory markers in women with high risk of thrombosis

InflammationThrombosisThrombopoiesisCardiovascular DiseaseBlood PlateletGynecologyOther Inflammatory MarkersC-reactive Protein LevelsInflammatory MarkerPlatelet AntagonistMedicineAtherosclerosisRheumatoid ArthritisWomen's HealthHigh Risk